Work

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome

Year: 2024

Type: article

Abstract: Idiopathic nephrotic syndrome is a rare disease characterized by edema, nephrotic-range proteinuria, and hypoalbuminemia. Although corticosteroids induce remission in almost 90% of patients, approximately 40% to 60% of cases develop frequent relapses and become steroid-dependent. These patients are often treated with steroid-sparing agents, to manage frequently relapsing or steroid-dependent nephrotic syndrome (SDNS).1

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2024.08.021